The Biden administration is expected to release the next batch of drugs that will be subject to Medicare price negotiations — ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

The UK's self-regulated system for disclosing payments from drug companies to health care professionals and organizations is ...